HIROTSUバイオサイエンス | 線虫がん検査に関する世界最先端の線虫行動解析技術

NEWS

Cancer test that uses nematodes N-NOSE® （エヌノーズ）

N-NOSE is a cancer screening test takes advantage of the keen olfactory sensors of nematodes. The test has been available to the public in Japan in January 2020.

N-NOSE service site
Learn More

What is N-NOSE?

Merit of taking a cancer screening test

Why nematodes?

The world's first biological ”diagnostic” technology.

At Hirotsu Bio Science, we contribute to the development of revolutionary disease diagnostic technologies to lessen your concerns over health.

Message from CEO
Learn More

Company Profile

Company History

SDGs

Advisers

News

N-NOSE was in “Kenpo News” of Kenporen (National Federation of Health Insurance Societies) September issue

2019.09.15

Nenpo News is published by Kenporen (National Federation of Health Insurance Societies) consists of 1,389 health insurance societies. N-NOSE was introduced in its Semptember issue.

Back

NEWS

Cancer test that uses nematodes N-NOSE® （エヌノーズ）

Learn More

Learn More

N-NOSE was in “Kenpo News” of Kenporen (National Federation of Health Insurance Societies) September issue

More

HIROTSU Bioscience Supports Japan’s New Health Guidelines with Scientifically Validated Cancer Screening

Demonstrating the Efficacy of N-NOSE in Detecting Hematological Malignancies was published in an international academic journal

HIROTSU Bioscience Corporation announces issuance of new shares to third-party investors